Adventitial Fibroblasts Release Interleukin 6 After Vascular Injury and Induce Smooth Muscle Cell Proliferation and...

Area of Science:

• Vascular Biology
• Immunology
• Regenerative Medicine

Background:

• Vascular restenosis and neointima formation limit percutaneous intervention efficacy.
• The adventitia's role in neointima formation and cell interactions remains unclear.

Purpose of the Study:

• To elucidate the role of adventitial fibroblasts in neointima formation.
• To investigate the signaling pathways involved in vascular injury response.

Main Methods:

• Analysis of human restenotic lesions and animal models (porcine, mouse).
• Investigated fibroblast proliferation, adventitial expansion, and leukocyte recruitment.
• Utilized interleukin 6 knockout mice and adventitial tissue transplantation models.

Main Results:

• Activated adventitial fibroblasts release interleukin 6, inducing smooth muscle cell (SMC) proliferation and migration in vitro.
• Interleukin 6 knockout impaired SMC response and prevented neointima formation.
• Medial SMCs, not resident adventitial cells, formed the neointima.

Conclusions:

• Adventitial fibroblasts act as a paracrine inflammatory engine via interleukin 6 release.
• This process drives medial SMC proliferation and migration, leading to neointima formation.
• Targeting adventitial inflammation offers a potential strategy to limit vascular restenosis.